| |
| |
|
| Insider
Information: |
Eshelman Fredric N |
| Relationship: |
10% Owner |
| City: |
Wilmington |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
8,151,654 |
|
|
Indirect Shares
|
3,933,809 |
|
|
| Direct
Value |
$83,566,297 |
|
|
|
Indirect Value
|
$18,625,640 |
|
|
| Total
Shares |
12,085,463 |
|
|
| Total
Value |
$102,191,938 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
7
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
-7.0
|
-3.0
|
| Percentage
Gain/Loss : |
 -45.7%
|
-43.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmaceutical Product Developme... |
PPDI |
Executive Chairman, Di... |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director, 10% Owner |
2014-07-02 |
0 |
2014-07-02 |
0 |
Premium* |
|
|
Bausch Health Companies Inc |
BHC |
Director |
2017-05-05 |
38,298 |
2016-03-11 |
0 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
Director, 10% Owner |
2017-11-13 |
250,000 |
2017-11-13 |
3,439,151 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2020-09-11 |
1,292,787 |
2020-09-11 |
319,085 |
Premium* |
|
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2020-11-25 |
6,570,569 |
2020-11-25 |
175,573 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LQDA |
Liquidia Technologies Inc |
10% Owner |
– – • |
2019-12-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,159,744 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Executive Officer |
• • • |
2004-07-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
22,000 |
4,964,263 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
Chief Executive Officer |
• • • |
2004-07-16 |
4/A |
GD |
$0.00 |
$0 |
D/D |
22,000 |
4,964,263 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2005-04-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
7,000 |
4,957,263 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2005-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
4,982,263 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
officerTitle |
• • – |
2005-12-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
47,000 |
4,915,263 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2006-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
74,492 |
9,350,626 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-12-05 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
8,450,636 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
190,000 |
8,260,626 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-12-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,000 |
8,254,626 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2007-12-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(100,000) |
8,154,626 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2008-08-06 |
4 |
GD |
$0.00 |
$0 |
D/D |
39,000 |
7,965,626 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2008-08-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
40,000 |
7,925,626 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2008-09-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
70,000 |
7,855,626 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
CEO |
• • – |
2009-03-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
100,000 |
7,755,626 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2009-06-18 |
4 |
A |
$0.00 |
$0 |
I/I |
11,258 |
11,258 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2009-06-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,258) |
7,744,368 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2009-08-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(500,000) |
7,244,368 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2009-08-28 |
4 |
A |
$0.00 |
$0 |
I/I |
500,000 |
500,000 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2010-04-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
100,000 |
7,144,368 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2010-04-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
7,134,368 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2010-05-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
36,497 |
7,097,871 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2010-09-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
75,000 |
7,022,871 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2010-09-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(37,500) |
462,500 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Executive Chairman |
• • – |
2010-09-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
62,500 |
6,960,371 |
0 |
- |
|
148 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
